drugset / Trial / NCT00799656
Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic Pain
RandomizedCrossoverDouble-blindTreatment
Summary
The primary objective of this study is to assess the efficacy of ataciguat versus placebo in reducing pain intensity in patients with neuropathic pain. The secondary objective is to assess the safety and tolerability of ataciguat versus placebo.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-06
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ataciguat | Small molecule | 200 mg | Oral |
Indications
No indication recorded.